Anna Seale

Dr. Anna Seale leads the foundation’s efforts to support the development and introduction of new maternal vaccines in low- and middle-income countries, including the first maternal vaccine for group B streptococcus (GBS).

Before joining the foundation in 2022, Anna was a professor of public health at the University of Warwick in the UK, and a scientific advisor for the UK Health Security Agency. This followed her work at the Department of Health and Social Care (UK), where she led public health analyses to inform the national response to COVID-19. Earlier, at the London School of Hygiene & Tropical Medicine (LSHTM), she held a Wellcome Trust Career Development Fellowship to investigate the infectious causes of perinatal mortality in Ethiopia and Kenya. She also led the first Child Health and Mortality Prevention Surveillance (CHAMPS) network site in Ethiopia, in partnership with Haramaya University. This work built on her research estimating the burden of GBS disease and describing the clinical and molecular epidemiology of GBS in Kenya.

Anna undertook her medical training at the University of Cambridge and University of Oxford, and subsequently completed specialist training in public health medicine. She completed her DPhil in epidemiology at the University of Oxford. She is an honorary professor at LSHTM and at the University of Warwick.